II Genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm

Stroke

Volumn 35, Issue 7, 2004, Pages 1594-1597

  Slowik, Agnieszka ^a   Borratynska, Anna ^a   Pera, Joanna ^a   Betlej, Marek ^a   Dziedzic, Tomasz ^a   Krzyszkowski, Tadeusz ^a   Czepko, Ryszard ^a   Figlewicz, Denise A ^b   Szczudlik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Aneurysm; Angiotensin converting enzyme; Genetics; Subarachnoid hemorrhage

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALLELE; ANEURYSM RUPTURE; ARTICLE; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTRON; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; ANEURYSM, RUPTURED; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLAND; POLYMORPHISM, GENETIC; RISK FACTORS; SUBARACHNOID HEMORRHAGE;

EID: 3042684295     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000131655.45227.f7     Document Type: Article

References (22)

1. Hop JW, Rinkel GJ, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke. 1997;28:660-664.
2. Yong-Zhong G, van Alphen HA. Pathogenesis and histopathology of saccular aneurysms: review of the literature. Neurol Res. 1990;12:249-255.
3. Kissela BM, Sauerbeck L, Woo D, Khoury J, Carrozzella J, Pancioli A, Jauch E, Moomaw CJ, Shukla R, Gebel J, Fontaine R, Broderick J. Subarachnoid hemorrhage: a preventable disease with a heritable comonent. Stroke. 2002;33:1321-1326.
4. Broderick JP, Viscoli MC, Brott T, Kernan WN, Brass LM, Feldman E, Morgenstern LB, Wilterdink JL, Horwitz RI. Hemorrhagic Stroke Project Investigators. Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable. Stroke. 2003;34:1375-1381.
5. Longstreth WT Jr, Nelson LM, Koepsell TD, van Belle G. Cigarette smoking, alcohol use, and subarachnoid hemorrhage. Stroke. 1992;23:1242-1429.
6. Juvela S, Hillborn M, Numminen H, Koskinen P. Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage. Stroke. 1993;24:639-646.
7. Belz MM, Fick-Brosnahan GM, Hughes RL, Rubinstein D, Chapman AB, Johnson AM, McFann KK, Kaehny WD, Gabow PA. Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease. Kidney Int. 2003;63:1824-1830.
8. Schievink WI, Limburg M, Oothuys JW, Fleury P, Pope FM. Cerebrovascular disease in Ehlers-Danlos syndrome type IV. Stroke. 1990;21:626-632.
9. Wills S, Ronkainen A, van der Voet M, Kuivaniemi H, Helin K, Leinonen E, Frosen J, Niemela N, Jaaskelainen J, Hernesniemi J, Tromp G. Familial intracranial aneurysms: an analysis of 346 multiplex Finnish families. Stroke. 2003;34:1370-1374.
10. Ohkuma H, Suzuki S, Fujita S, Nakamura W. Role of a decreased expression of the local renin-angiotensin system in the etiology of cerebral aneurysms. Circulation. 2003;108:785-787.
11. Takenaka K, Yamakawa H, Sakai H, Yoshimura S, Murase S, Okumura A, Nakatani K, Kimura T, Nishimura Y, Yoshimi N, Sakai N. Angiotensin I-converting enzyme gene polymorphism in intracranial saccular aneurysm individuals. Neurol Res. 1998;20:607-611.
12. Keramatipour M, McConnell RS, Kirkpatrick P, Tebbs S, Furlong RA, Rubinsztein DC. The ACE I allele is associated with increased risk for ruptured intracranial aneurysms. J Med Genet. 2000;37:498-500.
13. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/ deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992;20:1433.
14. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Appl. 1993;3:120-121.
15. Odawara M, Matsunuma A, Yamashita K. Mistyping frequency of the angiotensin converting enzyme gene polymorphism and an improved method for its avoidance. Hum Genet. 1997;100:163-166.
16. Banerjee RK, Gonzalez CF, Cho YI, Picard L. Hemodynamic changes in recurrent intracranial terminal aneurysm after endovascular treatment. Acad Radiol. 1996;3:202-211.
17. Stehbens WE. Etiology of intracranial berry aneurysms. J Neurosurg. 1989;70:823-831.
18. Brisman R, Abbassioun K. Familial intracranial aneurysms. J Neurosurg. 1971;34:678-682.
19. Inci S, Spetzler RF. Intracranial aneurysms and arterial hypertension: a review and hypothesis. Surg Neurol. 2000;53:530-542.
20. Niu T, Chen X, Xy X. Angiotensin converting enzyme gene insertion/ deletion polymorphism and cardiovascular diseases: therapeutic implications. Drugs. 2002;62:977-993.
21. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half of the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
22. Winkelmann BR, Nauck M, Klein B, Russ AP, Bohm BO, Siekmeier R, Ihnken K, Werho M, Gross W, Marz W. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease. Ann Intern Med. 1996;125:19-25.